Bowen Lou

479 total citations
26 papers, 268 citations indexed

About

Bowen Lou is a scholar working on Cardiology and Cardiovascular Medicine, Molecular Biology and Physiology. According to data from OpenAlex, Bowen Lou has authored 26 papers receiving a total of 268 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Cardiology and Cardiovascular Medicine, 9 papers in Molecular Biology and 7 papers in Physiology. Recurrent topics in Bowen Lou's work include Metabolomics and Mass Spectrometry Studies (5 papers), Adipose Tissue and Metabolism (5 papers) and Cardiovascular Function and Risk Factors (4 papers). Bowen Lou is often cited by papers focused on Metabolomics and Mass Spectrometry Studies (5 papers), Adipose Tissue and Metabolism (5 papers) and Cardiovascular Function and Risk Factors (4 papers). Bowen Lou collaborates with scholars based in China, Germany and Taiwan. Bowen Lou's co-authors include Jianqing She, Zuyi Yuan, Bo Zhou, Haoyu Wu, Jens Krøll, Yue Wu, Zuyi Yuan, Katrin Bennewitz, Chen Wang and Junhui Liu and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and The FASEB Journal.

In The Last Decade

Bowen Lou

25 papers receiving 267 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Bowen Lou China 11 107 86 45 43 33 26 268
Yu Hashimoto Japan 10 68 0.6× 73 0.8× 46 1.0× 32 0.7× 25 0.8× 42 229
Christine Rossmann Austria 11 107 1.0× 83 1.0× 55 1.2× 42 1.0× 62 1.9× 18 348
Jae Eun Jun South Korea 7 146 1.4× 146 1.7× 55 1.2× 29 0.7× 34 1.0× 36 339
Dating Sun China 10 98 0.9× 46 0.5× 35 0.8× 38 0.9× 48 1.5× 12 218
Jiandi Wu China 9 82 0.8× 68 0.8× 37 0.8× 71 1.7× 66 2.0× 20 267
Maxim Soloviev United States 8 96 0.9× 86 1.0× 30 0.7× 89 2.1× 33 1.0× 13 270
Teuku Heriansyah Indonesia 11 87 0.8× 135 1.6× 77 1.7× 25 0.6× 46 1.4× 59 392
Ana B. Hidalgo Spain 10 105 1.0× 29 0.3× 50 1.1× 51 1.2× 37 1.1× 18 295
Irina Bobkova Russia 9 88 0.8× 26 0.3× 25 0.6× 33 0.8× 40 1.2× 61 264
Eva Maria Brandtner Austria 10 95 0.9× 52 0.6× 56 1.2× 35 0.8× 50 1.5× 32 352

Countries citing papers authored by Bowen Lou

Since Specialization
Citations

This map shows the geographic impact of Bowen Lou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Bowen Lou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Bowen Lou more than expected).

Fields of papers citing papers by Bowen Lou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Bowen Lou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Bowen Lou. The network helps show where Bowen Lou may publish in the future.

Co-authorship network of co-authors of Bowen Lou

This figure shows the co-authorship network connecting the top 25 collaborators of Bowen Lou. A scholar is included among the top collaborators of Bowen Lou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Bowen Lou. Bowen Lou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhang, Xinyu, Wei Zhou, Hongxing Liu, et al.. (2025). Initiation of vericiguat and short-term cardiovascular function improvement in heart failure patients with and without worsened renal function. Frontiers in Cardiovascular Medicine. 12. 1628411–1628411.
2.
Lou, Bowen, Tao Zheng, Junhui Liu, et al.. (2024). Single‐cell RNA sequencing reveals the altered innate immunity in immune checkpoint inhibitor‐related myocarditis. Immunology. 172(2). 235–251. 5 indexed citations
3.
Liu, Junhui, Xi Wen, Peining Liu, et al.. (2024). Gut Microbiota Regulate Saturated Free Fatty Acid Metabolism in Heart Failure. SHILAP Revista de lepidopterología. 4(9). 2300337–2300337. 2 indexed citations
4.
Xin, Qian, Stephan Klatt, Katrin Bennewitz, et al.. (2023). Impaired Detoxification of Trans, Trans‐2,4‐Decadienal, an Oxidation Product from Omega‐6 Fatty Acids, Alters Insulin Signaling, Gluconeogenesis and Promotes Microvascular Disease. Advanced Science. 11(4). e2302325–e2302325. 6 indexed citations
5.
Lou, Bowen, Haoyu Wu, Katrin Bennewitz, et al.. (2023). Increased circulating uric acid aggravates heart failure via impaired fatty acid metabolism. Journal of Translational Medicine. 21(1). 199–199. 15 indexed citations
6.
Lou, Bowen, Haoyu Wu, Hui Liu, et al.. (2022). Association between Cystatin C and Cardiac Function in Acute Myocardial Infarction Patients: A Real-World Analysis. Disease Markers. 2022. 1–12. 5 indexed citations
7.
Lou, Bowen, Hui Liu, Haoyu Wu, et al.. (2022). In-hospital initiation of PCSK9 inhibitor and short-term lipid control in patients with acute myocardial infarction. Lipids in Health and Disease. 21(1). 105–105. 9 indexed citations
8.
Lou, Bowen, Jakob Morgenstern, Thomas Fleming, et al.. (2022). Accumulation of acetaldehyde in aldh2.1 zebrafish causes increased retinal angiogenesis and impaired glucose metabolism. Redox Biology. 50. 102249–102249. 16 indexed citations
9.
Zhou, Bo, Haoyu Wu, Chen Wang, Bowen Lou, & Jianqing She. (2021). Impact of Age, Sex, and Renal Function on the Efficacy and Safety of Direct Oral Anticoagulants vs. Vitamin K Antagonists for the Treatment of Acute Venous Thromboembolism: A Meta-Analysis of 22,040 Patients. Frontiers in Cardiovascular Medicine. 8. 700740–700740. 4 indexed citations
10.
Lou, Bowen, et al.. (2021). Interplay Between Gut Microbiota and Amino Acid Metabolism in Heart Failure. Frontiers in Cardiovascular Medicine. 8. 752241–752241. 12 indexed citations
11.
Wang, Chen, Haoyu Wu, Bowen Lou, et al.. (2021). Targeted metabolomic analysis of plasma fatty acids in acute myocardial infarction in young adults. Nutrition Metabolism and Cardiovascular Diseases. 31(11). 3131–3141. 21 indexed citations
12.
She, Jianqing, Bowen Lou, Hui Liu, et al.. (2021). ARNI Versus ACEI/ARB in Reducing Cardiovascular Outcomes After Myocardial Infarction. ESC Heart Failure. 8(6). 4607–4616. 21 indexed citations
13.
Yang, Lin, Liang Wang, Yangyang Deng, et al.. (2020). Serum lipids profiling perturbances in patients with ischemic heart disease and ischemic cardiomyopathy. Lipids in Health and Disease. 19(1). 89–89. 16 indexed citations
14.
Lou, Bowen, Katrin Bennewitz, Carsten Sticht, et al.. (2020). Elevated 4-hydroxynonenal induces hyperglycaemia via Aldh3a1 loss in zebrafish and associates with diabetes progression in humans. Redox Biology. 37. 101723–101723. 40 indexed citations
16.
Zhou, Bo, Bowen Lou, Junhui Liu, & Jianqing She. (2020). Serum metabolite profiles as potential biochemical markers in young adults with community-acquired pneumonia cured by moxifloxacin therapy. Scientific Reports. 10(1). 4436–4436. 13 indexed citations
17.
Lou, Bowen, Hao Xiang, Lizhe Sun, et al.. (2019). Clinical Characteristics and Protective Factors in Patients with Acute Myocardial Infarction Undergoing in-Hospital Myocardial Free Wall Rupture: A Single-Center, Retrospective Analysis. Journal of Investigative Medicine. 67(8). 1097–1102. 9 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026